Tate & Lyle PLC
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Tate & Lyle PLC (TATE.L) is a global provider of specialty food and beverage ingredients and solutions, focusing on high-value products that enhance taste, texture, nutrition, and sustainability in consumer and industrial applications. The company offers a diverse portfolio including low- and no-calorie sweeteners such as SPLENDA sucralose and TASTEVA stevia; soluble fibers like PROMITOR; texturants and stabilizers such as CLARIA functional clean-label starch; crystalline fructose under the KRYSTAR brand; pectin and specialty gums through its CP Kelco segment; high-volume sweeteners and industrial starches in Primary Products Europe; and solutions for beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, meat and seafood, personal care, household products, clinical nutrition, and industrial uses. Headquartered in London, United Kingdom, and founded in 1903, Tate & Lyle operates manufacturing facilities and innovation centers across more than 60 locations worldwide, including key sites in the United States, Europe, Asia Pacific, and Latin America, serving food and beverage manufacturers, personal care, and industrial markets. In a major strategic expansion, the company completed its acquisition of CP Kelco from J.M. Huber in November 2024 for approximately £1.4 billion, integrating pectin, specialty gums, and nature-based ingredients to strengthen its texturants portfolio and target growth in the $19 billion specialty ingredients market. Earlier in 2024, Tate & Lyle divested its remaining 49.7% stake in the Primient joint venture to KPS Capital Partners for $350 million, fully exiting legacy bulk corn processing operations to focus on higher-margin specialty solutions; it also extended its regenerative agriculture program into Europe and deepened partnerships like its stevia Reb M collaboration with Manus Bio. These moves support accelerated revenue growth toward 4-6% annually, cost synergies of £40 million, and innovation in sugar reduction, fiber fortification, and GLP-1 medication-aligned consumer trends.
Company News
BioHarvest says its platform can produce target sweetener in Tate & Lyle program
Tate & Lyle PLC (OTCMKTS:TATYY) Sees Significant Growth in Short Interest
Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal
Tate & Lyle agrees £3.8bn takeover by US rival
Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle
UK's Tate & Lyle agrees $3.6 billion Ingredion takeover
Tate & Lyle plc (TATYY) Q4 2026 Earnings Call Transcript
Tate & Lyle H2 Earnings Call Highlights
Ingredion Takeover Target Tate & Lyle Posts Fall in Profit
BioHarvest Sciences and Tate & Lyle expand sweetener development program
Tate & Lyle is a sweet opportunity for bidders says broker
Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer
Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid
Tate & Lyle (OTCMKTS:TATYY) Shares Gap Up – Should You Buy?
Critical Contrast: Armanino Foods of Distinction (OTCMKTS:AMNF) & Tate & Lyle (OTCMKTS:TATYY)
Tate & Lyle (OTCMKTS:TATYY) versus Kraft Heinz (NASDAQ:KHC) Head-To-Head Survey
Head to Head Contrast: Ingredion (NYSE:INGR) and Tate & Lyle (OTCMKTS:TATYY)
Tate & Lyle (OTCMKTS:TATYY) Shares Gap Down – Should You Sell?
Tate & Lyle plc (TATYY) Q3 2026 Earnings Call Transcript
Tate & Lyle PLC (OTCMKTS:TATYY) Given Average Recommendation of “Hold” by Analysts